Chimera Bioengineering
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
610 Gilbert Ave Apt 16, Menlo Park, Cali...Phone Number
(310) 430-9893Website
chimera.bioRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
3
2
3
About Chimera Bioengineering
Chimera Bioengineering specializes in CAR-T cell therapy, utilizing novel genetic engineering technology to enhance the efficacy and safety of cell therapies for cancer treatment. The company focuses on addressing the challenges of solid tumors by developing engineered T-cells that target specific tumor antigens, aiming to improve patient outcomes while preserving their dignity. Their mission is to transform the landscape of cancer treatment by providing innovative therapies that attack tumors without harming the patient. Based in South San Francisco, Chimera Bioengineering is committed to creating a new class of cancer therapies that leverage the body's immune system to combat cancer more effectively.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chimera Bioengineering your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Chimera Bioengineering launches new products
Chimera Bioengineering, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Chimera Bioengineering has recently received funding, and reach out quickly before it becomes old news!
Click to see if Chimera Bioengineering had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Chimera Bioengineering
Earning: See what the market has to say on Chimera Bioengineering recently announced quarterly report
Funding: Get notified immidiatlly once Chimera Bioengineering has new funding data
Website visits: Recent activity has been detected on your website
Check out if Chimera Bioengineering is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Chimera Bioengineering
Compare insights from companies similar to Chimera Bioengineering, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Chimera Bioengineering
<$5M
11-50
Private
<$5M
2015
N/A
Company Profile Activity
Activity Insights
Chimera Bioengineering is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Chimera Bioengineering is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Chimera Bioengineering.
Chimera Bioengineering financials insights
Gather financial insights about Chimera Bioengineering, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$235K
Chimera Bioengineering Tech Stack
A closer look at the technologies used by Chimera Bioengineering
Most Recent Scoops
New Hire
Executive Move
Lateral Move
Executive Move
Funding
Chimera Bioengineering has received an SBA PPP loan in the amount of $235,137 from Silicon Valley Bank resulting in the retention of 14 jobs.
Funding
Chimera Bioengineering News & Media
Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #afcr--Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chimera Bioengineering
Sign Up For FreeTo access detailed company insights
Chimera Bioengineering specializes in CAR-T cell therapy, utilizing novel genetic engineering technology to enhance the efficacy and safety of cell therapies for cancer treatment. The company focuses on addressing the challenges of solid tumors by developing engineered T-cells that target specific tumor antigens, aiming to improve patient outcomes... Read More
